For instance, CDK4 and CDK6 are frequently activated in human cancer, either by overexpression of their activating subunits, D-type cyclins, or inactivation of CDK4/6 inhibitors of the INK4 protein family, and they play an essential role in cell cycle entry and G1 progression [76,77,78]. Here, CDK4 is linked to cancer.